Abstract
Recent data on neuronal cytoskeletal pathology of Lewy bodies, a major anatomical hallmark of PD, suggest pathological phosphorylation of neurofilament proteins with ubiquitination, but their relation to neuromelanin and cell degeneration is unknown. Quantitative morphological studies in PD indicate that in addition to nigrostriatal dopaminergic pathways, other dopaminergic, noradrenergic, serotonergic, and cholinergic systems are involved, causing multiple neuromediator dysfunctions. Dementia in PD is not only related to cortical AD pathology, but also to a variety of central nervous system lesions.
Keywords
NeuroscienceNeuromelaninPathologyDopaminergicSerotonergicParkinson's diseaseMedicineCentral nervous systemLewy bodySubstantia nigraDiseaseBiologyDopamineInternal medicineSerotonin
Affiliated Institutions
Related Publications
Altered <i>Tau</i> and Neurofilament Proteins in Neuro‐Degenerative Diseases: Diagnostic Implications for Alzheimer's Disease and Lewy Body Dementias
The neuronal cytoskeleton is one of the most profoundly altered organelles in late life neurodegenerative disorders that are characterized by progressive impairments in cognitiv...
Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease
Immunocytochemistry with antibodies to ubiquitin is currently the most sensitive method for detecting cortical Lewy bodies, which are a sine qua non for the diagnosis of diffuse...
Where Does Parkinson Disease Pathology Begin in the Brain?
The substantia nigra is not the induction site in the brain of the neurodegenerative process underlying Parkinson disease (PD). Instead, the results of this semi-quantitative st...
Publication Info
- Year
- 1990
- Type
- article
- Volume
- 53
- Pages
- 1-16
- Citations
- 102
- Access
- Closed
External Links
Citation Metrics
102
OpenAlex
Cite This
K. A. Jellinger
(1990).
New developments in the pathology of Parkinson's disease..
PubMed
, 53
, 1-16.